Page last updated: 2024-10-23

bethanidine and Coronary Disease

bethanidine has been researched along with Coronary Disease in 3 studies

Bethanidine: A guanidinium antihypertensive agent that acts by blocking adrenergic transmission. The precise mode of action is not clear.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"In all cases, arrhythmias were preceded by and appeared to be temporally related to progressive fractionation and delay of electrograms recorded from the ischemic zone."5.28Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. ( Kabell, G, 1989)
"In all cases, arrhythmias were preceded by and appeared to be temporally related to progressive fractionation and delay of electrograms recorded from the ischemic zone."1.28Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate. ( Kabell, G, 1989)
"These arrhythmias occurred during the period of occlusion and even more prominently after release of the occlusion."1.27A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro. ( Northover, BJ, 1985)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilhelmsen, L1
Berglund, G1
Sannerstedt, R1
Hansson, L1
Andersson, O1
Sievertsson, R1
Wikstrand, J1
Kabell, G1
Northover, BJ1

Other Studies

3 other studies available for bethanidine and Coronary Disease

ArticleYear
Effect of treatment of hypertension in the primary preventive trial, Göteborg, Sweden.
    British journal of clinical pharmacology, 1979, Volume: 7 Suppl 2

    Topics: Adrenergic beta-Antagonists; Bethanidine; Cardiovascular Diseases; Cerebrovascular Disorders; Corona

1979
Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Journal of cardiovascular pharmacology, 1989, Volume: 13, Issue:3

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bethanidine; Bretylium Compounds; Bretylium Tosyla

1989
A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.
    British journal of pharmacology, 1985, Volume: 84, Issue:3

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bethanidine; Coronary Dise

1985